Trials / Terminated
TerminatedNCT07035067
Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (actual)
- Sponsor
- PeriPharm · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Filling the gap in Canadian evidence on the burden of PROC on QoL is essential. It will help better understand the impact of PROC on multiple aspects of the lives of patients and their caregivers and the real-life hurdles faced by PROC patients and their caregivers. The outputs of this study will help better understand the hurdles and challenges they face and the significant unmet medical need.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No specific intervention is assess in this study. |
Timeline
- Start date
- 2025-07-15
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2025-06-24
- Last updated
- 2026-04-07
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT07035067. Inclusion in this directory is not an endorsement.